Brussels, 26/06/2006 (Agence Europe) - In a report published on Monday 26 June, the European Commission welcomed the five years of progress made in the application of a regulation on Orphan medicinal products. Between April 2000 and April 2005, the centralised authorisation procedure for marketing the European Agency for the Evaluation of Medicinal Products (EMEA) in London and the incentive programme, triggered more than 450 applications for orphan designation. Some 270 further medicines...